These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5873680)

  • 41. Disposition of four drugs in malnourished children.
    Mehta S; Nain CK; Sharma B; Mathur VS
    Drug Nutr Interact; 1982; 1(3):205-11. PubMed ID: 6821389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pharmacokinetics of a chloramphenicol-rifampicin combination in rats].
    Cantelli Forti G; Fracasso ME
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):575-7. PubMed ID: 5140771
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chloramphenicol metabolism in the tissues of newborn and adult rabbits].
    Prokopczyk L; Jahn-Andrychowska W; Wańkowicz B; Kamińska E
    Probl Med Wieku Rozwoj; 1984; 13():198-206. PubMed ID: 6531349
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Physicochemical properties and intestinal absorption of a ground mixture of chloramphenicol palmitate with microcrystalline cellulose (author's transl].
    Yamamoto K; Matsuda S; Nakano M; Arita T; Nakai Y
    Yakugaku Zasshi; 1977 Apr; 97(4):367-72. PubMed ID: 559740
    [No Abstract]   [Full Text] [Related]  

  • 45. [Rheological studies and biopharmaceutical evaluation of ointments containing selected antibiotics. II. Effect of the ointment base on rheological properties and the rate of liberation and absorption of chloramphenicol].
    Zakrzewski Z; Hudemowicz W
    Acta Pol Pharm; 1981; 38(1):99-105. PubMed ID: 7315463
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bioavailability of chloramphenicol palmitate suspension].
    Morasso MI; Hirmas E; Firmani E; Pezoa R; Cid E
    Pharm Acta Helv; 1980; 55(10):270-3. PubMed ID: 7454734
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of aluminum hydroxide on the intestinal absorption of chloramphenicol.
    TAKASU T; BOSCO L; CLARK BJ; MARRARO HW
    N Engl J Med; 1958 Oct; 259(16):767-70. PubMed ID: 13590445
    [No Abstract]   [Full Text] [Related]  

  • 48. [Study on the blood picture after administration of different chloramphenicol palmitate suspensions].
    van ZEBEN ; BASTMEYER DJ
    Ned Tijdschr Geneeskd; 1962 Aug; 106():1583-8. PubMed ID: 14009983
    [No Abstract]   [Full Text] [Related]  

  • 49. The particle size evaluation of parenteral suspensions of chloramphenicol and correlation of particle size to plasma levels.
    Kitamori N; Kawajiri S; Matsuzawa T
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2597-602. PubMed ID: 1017098
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of water deprivation on chloramphenicol disposition kinetics in humans.
    Ahmad T; Parveen G; Niazi S
    J Pharm Sci; 1982 Nov; 71(11):1309-10. PubMed ID: 7175736
    [No Abstract]   [Full Text] [Related]  

  • 51. Metabolism of chloramphenicol: a story of nearly 50 years.
    Bories GF; Cravedi JP
    Drug Metab Rev; 1994; 26(4):767-83. PubMed ID: 7875065
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of physicochemical properties and intestinal region on the absorption of 3-fluoro-2-pyrimidylmethyl 3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide, a water insoluble thrombin inhibitor, in dogs.
    Euler D; Frech P; Karki S; Cowden C; Pearce G; Mehta P; Lindemann C; Byway P; Wang M; Gibson T; Cheng Y; Kwei G; Rose J
    Int J Pharm; 2004 May; 275(1-2):19-27. PubMed ID: 15081135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal excretion and intestinal absorption of D-chloramphenicol.
    SCHUCK O; CHOLINSKY K; SMAHEL O; GRAFNETTEROVA J
    Antibiotic Med Clin Ther (New York); 1959 Feb; 6(2):98-102. PubMed ID: 13628036
    [No Abstract]   [Full Text] [Related]  

  • 54. [Chloramphenicol glycinate: studies of absorption and elimination in humans].
    CONTI F; CASSANO A; MAZZEO M; FARULLA A
    Riforma Med; 1958 Nov; 72(47):1325-7. PubMed ID: 13624519
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on leucomycin A1. II. Studies on blood and tissue levels, and toxicities.
    Hoshino Y; Umezawa I; Yamamoto H; Matsumae A; Hata T
    J Antibiot (Tokyo); 1966 Jan; 19(1):30-6. PubMed ID: 5952019
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of hemodialysis on total body clearance of chloramphenicol.
    Slaughter RL; Cerra FB; Koup JR
    Am J Hosp Pharm; 1980 Aug; 37(8):1083-6. PubMed ID: 7405936
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Changes in chloramphenicol metabolism (induction) after treatment with nicotinic acid diethylamide].
    Pantané S
    Boll Soc Ital Biol Sper; 1966 Sep; 42(17):1158-60. PubMed ID: 5971366
    [No Abstract]   [Full Text] [Related]  

  • 58. Absorption of the new anxiolytic compound deramciclane in rats, dogs and rabbits.
    Lengyel J; Bolehovszky A; Klebovich I; Aberman M; Magyar K
    Arzneimittelforschung; 1998 May; 48(5):455-60. PubMed ID: 9638311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of chloramphenicol oxamic acid as a new major metabolite of chloramphenicol in rats.
    Wal JM; Peleran JC; Bories GF
    FEBS Lett; 1980 Sep; 119(1):38-42. PubMed ID: 7428925
    [No Abstract]   [Full Text] [Related]  

  • 60. Blood flow an intestinal absorption.
    Mailman D
    Fed Proc; 1982 Apr; 41(6):2096-100. PubMed ID: 6122606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.